Alectinib (marketed as Alecensa® in the U.S.) can be quite expensive, and the price you’ll see depends on where you live, your insurance, and whether you’re using a co‑pay card or patient‑assistance program. Below is a quick snapshot of what you might expect in a few major markets:
| Region | Typical Out‑of‑Pocket Cost (per year) | Notes |
|--------|-------------------------------------|-------|
| United States | $60 000 – $70 000 (average retail) | Retail price is usually the highest—often $4,000–$5,000/month. Most people pay less if they have commercial insurance, Medicare Part D, or a manufacturer co‑pay card. |
| Canada | CAD 25 000 – CAD 35 000 | Prices are lower than in the U.S. due to universal coverage, but the drug is still listed as a high‑cost medicine. |
| United Kingdom | £15 000 – £20 000 | The NHS may negotiate lower prices; patients usually pay a small co‑pay or use a patient‑assistance scheme. |
| Australia | AUD 30 000 – AUD 40 000 | Covered under the PBS (Pharmaceutical Benefits Scheme) with a modest co‑pay. |
Bottom line: Alectinib is a high‑cost specialty drug. Even if your insurance covers a large portion, the yearly cost can still be in the tens of thousands of dollars.
---
How to Check Your Exact Cost
1. Ask Your Pharmacist
- They can give you the current retail price and any available discounts or coupons.
2. Use Online Tools
- GoodRx (U.S.) – shows price variations at different pharmacies and available coupons.
- Canada Pharmacy – similar comparison for Canadian prices.
3. Check with Your Insurer
- Your insurer’s portal often lists the “usual, customary, and reasonable” (UCR) price for a drug and whether a prior‑authorization or step‑therapy is required.
4. Manufacturer’s Assistance Program
- AstraZeneca offers an Alecensa® Patient Assistance Program for patients who meet income eligibility criteria.
- Many co‑pay cards can reduce your monthly out‑of‑pocket cost to a few hundred dollars or less.
---
What You Can Do If the Cost Is a Barrier
| Step | What to Do | Why It Helps |
|------|------------|--------------|
| 1. Talk to Your Oncologist | Ask if a generic or alternative ALK inhibitor might be suitable. | Some newer generics (or other ALK inhibitors like lorlatinib) are becoming available at lower cost. |
| 2. Apply for a Co‑Pay Card | Fill out the online application on AstraZeneca’s website. | Many patients see a 60‑90 % reduction in monthly cost. |
| 3. File a Patient‑Assistance Application | Provide income and insurance details. | If you qualify, you may receive the drug free of charge or at a heavily discounted price. |
| 4. Ask for a Prior‑Authorization | Your oncologist can submit the required paperwork. | Insurance often covers the drug at a negotiated rate. |
| 5. Compare Pharmacy Prices | Use tools like GoodRx or your local pharmacy’s discount program. | Even small savings add up over a year. |
---
Quick FAQ
| Question | Answer |
|----------|--------|
| Is the cost the same in all countries? | No. Prices are negotiated differently in each market. |
| Do insurance plans always cover the full amount? | Typically, insurers cover a large portion, but you’ll still have a co‑pay, coinsurance, or deductible to meet. |
| Can I get a generic version? | As of 2024, no generic alectinib is on the market. The drug remains protected by its patents. |
| What if I’m uninsured? | Contact AstraZeneca’s Patient Assistance Program or look for charitable foundations that help with cancer medication costs. |
---
Bottom‑Line Takeaway
Alectinib is a high‑cost specialty drug—in the U.S., expect $60–$70k per year before insurance, and even lower in other countries thanks to public formularies or negotiated discounts. Use your insurer’s portal, pharmacy price‑comparison sites, and the manufacturer’s patient‑assistance options to see what you can actually pay. If cost is a barrier, speak with your oncologist and pharmacist—they often have experience navigating these programs and can help you find the most affordable pathway to treatment.